Show simple item record

dc.contributor.authorCalifano, Andrea
dc.date.accessioned2010-09-27T20:26:14Z
dc.date.available2010-09-27T20:26:14Z
dc.date.issued2010-09-09
dc.identifier.urihttp://hdl.handle.net/1853/34915
dc.descriptionAndrea Califano from Columbia University presented a lecture on Tuesday, September 21, 2010 from 11:00 AM to 12:00 PM in the Klaus Advance Computing Building, Room 1116E on the Georgia Tech Campus.en_US
dc.descriptionRuntime: 71:51 minutes
dc.description.abstractThe identification of genes acting synergistically as master regulators of physiologic and pathologic cellular phenotypes is a key open problem in systems biology, Here we use a molecular interaction based approach to identify the repertoire of transcription factors (TFs) of a master regulatory module responsible for synergistic activation of a tumor-specific signature. Specifically, we used the ARACNe algorithm and other computational tools to infer regulatory interactions responsible for initiating and maintaining the mesenchymal phenotype of Glioblastoma Multiforme (GBM), previously associated with the poorest disease prognosis. Expression of mesenchymal genes is a hallmark of aggressiveness but the upstream regulators of the signature are unknown. Starting from the unbiased analysis of all TFs, we identify a highly interconnected module of six TFs jointly regulating >75% of the genes in the signature. Two TFs (Stat3 and C/EBPb), in particular, display features of initiators and master regulators of module activity. Biochemical validation confirms that the TFs in the module bind to the inferred promoters in vivo and ectopic expression of the master TFs activates expression of the mesenchymal signature. These effects are sufficient to trigger mesenchymal transformation of neural stem cells, which become highly tumorigenic in vivo, and promote migration and invasion. Conversely, silencing of Stat3 and C/EBPb in human glioma cells leads to collapse of the mesenchymal signature and reduction of tumor aggressiveness. Our results reveal that activation of a small transcriptional module is necessary and sufficient to induce a mesenchymal phenotype in malignant brain tumors.en_US
dc.format.extent71:51 minutes
dc.language.isoen_USen_US
dc.publisherGeorgia Institute of Technologyen_US
dc.subjectARACNe algorithmen_US
dc.subjectTranscription factorsen_US
dc.subjectMesenchymal transformationen_US
dc.subjectNeural stem cellsen_US
dc.subjectGlioblastoma Multiforme (GBM)en_US
dc.titleElucidating master integrators of tumor-related phenotypesen_US
dc.typeLectureen_US
dc.typeVideoen_US
dc.contributor.corporatenameColumbia University


Files in this item

This item appears in the following Collection(s)

Show simple item record